• Most Popular
  • Most Shared

Curis says Ortho Biotech plans to end license agreement

Fri May 18, 2007 5:25pm EDT

Stocks

   

May 18 (Reuters) - Drug developer Curis Inc. (CRIS.O) said Ortho Biotech Products L.P. plans to terminate the license agreement with Curis and cease its development efforts on the BMP-7 program for kidney and other diseases.

Mergers & Acquisitions

Preclinical research efforts on bone morphogenetic protein-7 molecules have been ongoing at Ortho Biotech Products L.P. since November 2002 under a license agreement between the parties, the company said in a statement.

The agreement will terminate on Aug. 16, it said. (Reporting by Shikhar Balwani in Bangalore)

Mergers & Acquisitions


More from Reuters

Joint Terminal Attack Controller SSgt Clinton J. Herbison, a U.S. Airman from the 817 Expeditionary Air Support Operations Squadron (EASOS) takes a break during a night mission near Honaker Miracle camp at the Pesh valley of Kunar Province August 12, 2009. Credit: REUTERS/Carlos Barria

Pictures of the Year

A look at the best photos of 2009.  Slideshow 

    PICTURES
    The Dalai Lama jokes with a nasal spray after being asked his opinion on the swine flu during a press conference after his first lecture in Lausanne, Switzerland, August 4, 2009. REUTERS/ Valentin Flauraud

    What a wacky year it's been...

    Um, what's up the Dalai Lama's nose? "Oddly Enough" editor Bob Basler rounds up the goofiest photos of the year.  Full Article 

    Oddly Enough
    A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
    Political Risk in 2010:

    Don't say we didn't warn you

    With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article 

    Global Markets